Ibex LTD Form 4 insider transactions

IBEX Ltd reports a net share settlement by Chief Sales/Marketing Officer Julie K. Casteel to cover tax liabilities upon vesting of restricted stock units.

IBEX Ltd. reports a net share settlement for Chief Operating Officer David Martin Afdahl, involving shares withheld for tax liabilities upon restricted stock unit vesting.

IBEX Ltd reports a net share settlement for tax liabilities by Chief Legal Officer Christina Alice Trofimuk-O'Connor.

Bruce Neil Dawson of IBEX Ltd reported a transaction involving 886 common shares, settled to cover tax liabilities upon the vesting of restricted stock units.

Julie K. Casteel, Chief Sales/Marketing Officer of IBEX Ltd, sold 3,600 common shares at a weighted average price of $30.6065.

Director Patrick McGinnis sold 1,030 common shares of IBEX Ltd at a price of $31.69 per share.

IBEX Limited CFO Taylor Greenwald acquired 3,333 common shares via performance-based units and sold 964 shares to cover tax obligations.

IBEX Limited CEO Robert Dechant sold 7,800 common shares at a weighted average price of $30.4996 per share.

Chief Sales and CS Officer Bruce Dawson sold 18,389 common shares of IBEX Ltd across two transactions in May 2026.

Director Daniella Ballou-Aares reported the sale of 6,500 common shares of IBEX Ltd across multiple transactions.

IBEX Ltd. Director John William Jones was granted 2,250 restricted stock units, vesting over four years.

IBEX Ltd director Mingzhe Zhuang received a grant of 2,083 restricted stock units, vesting over four years.

IBEX Ltd. Director Daniella Ballou-Aares was granted 2,083 restricted stock units, vesting over four years starting July 1, 2026.

IBEX Ltd Director Patrick McGinnis was granted 2,083 restricted stock units, vesting over four years.

IBEX Ltd. Director Fiona Elizabeth Beck received a grant of 2,083 restricted stock units, aligning her interests with shareholders.

IBEX Ltd director Karen Batungbacal was granted 2,083 restricted stock units, aligning her interests with shareholders.

IBEX Ltd. Director Shuja Keen was granted 5,000 restricted stock units, which will vest over a four-year period.

IBEX Ltd's CEO and Director, Robert Thomas Dechant, was granted 18,000 restricted stock units vesting over four years.

IBEX Ltd's Chief Financial Officer, Taylor C. Greenwald, was granted 5,500 restricted stock units vesting over four years.

IBEX Ltd.'s Chief Operating Officer, David Martin Afdahl, was granted 4,400 restricted stock units vesting over four years.

IBEX Ltd's Chief Sales/Marketing Officer, Julie K Casteel, was granted 4,400 restricted stock units, vesting over four years.

IBEX Ltd's Chief Sales and CS Officer, Bruce Neil Dawson, was granted 3,250 restricted stock units, vesting over four years.

IBEX Ltd's Chief Legal Officer, Christina Alice Trofimuk-O'Connor, was granted 4,400 restricted stock units, aligning her interests with shareholders.

IBEX Ltd's Chief People Officer, Paul Joseph Inson, was granted 4,000 restricted stock units, vesting over four years.

IBEX Ltd's Chief AI & Digital Officer, Michael Joseph Darwal, reported a non-discretionary transfer of 925 common shares at $28.39 per share due to a divorce settlement.

IBEX Ltd's CEO, Robert Thomas Dechant, sold 6,000 common shares for a weighted average price of $28.4588 per share under a pre-arranged 10b5-1 plan.

IBEX Chief Sales/Marketing Officer Julie K. Casteel reported the vesting of performance-based restricted stock and subsequent tax-related share disposition.

IBEX Ltd's Chief Legal Officer, Christina Trofimuk-O'Connor, reported the vesting of performance-based restricted stock and subsequent tax-related share withholding.

IBEX Ltd's Chief Operating Officer, David Martin Afdahl, received 109,708 common shares as a restricted stock award tied to performance targets, with a portion withheld for taxes.

IBEX Ltd.'s Chief Financial Officer, Taylor C. Greenwald, received a restricted stock award of 20,000 common shares, with a portion vesting on February 6, 2026, and shares withheld for tax purposes.